Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bovie Medical Co. stock logo
BVX
Bovie Medical
$6.48
+1.1%
$6.48
$2.28
$7.70
$215.14MN/A136,878 shs129,500 shs
Crh Plc stock logo
CRH
CRH
$111.33
+0.1%
$109.86
$86.82
$131.55
$74.33B1.314.25 million shs6.93 million shs
5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bovie Medical Co. stock logo
BVX
Bovie Medical
0.00%0.00%0.00%0.00%0.00%
Crh Plc stock logo
CRH
CRH
-0.10%+1.42%+10.81%+4.51%+26.35%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bovie Medical Co. stock logo
BVX
Bovie Medical
$6.48
+1.1%
$6.48
$2.28
$7.70
$215.14MN/A136,878 shs129,500 shs
Crh Plc stock logo
CRH
CRH
$111.33
+0.1%
$109.86
$86.82
$131.55
$74.33B1.314.25 million shs6.93 million shs
5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bovie Medical Co. stock logo
BVX
Bovie Medical
0.00%0.00%0.00%0.00%0.00%
Crh Plc stock logo
CRH
CRH
-0.10%+1.42%+10.81%+4.51%+26.35%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bovie Medical Co. stock logo
BVX
Bovie Medical
0.00
N/AN/AN/A
Crh Plc stock logo
CRH
CRH
2.94
Moderate Buy$139.5425.33% Upside

Current Analyst Ratings Breakdown

Latest CRH, BVX, and TSTL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/18/2026
Crh Plc stock logo
CRH
CRH
DowngradeHold (C+)Hold (C)
5/4/2026
Crh Plc stock logo
CRH
CRH
DowngradeBuy (B)Hold (C+)
4/15/2026
Crh Plc stock logo
CRH
CRH
Reiterated RatingOverweight$139.00
(Data available from 6/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bovie Medical Co. stock logo
BVX
Bovie Medical
N/AN/AN/AN/AN/AN/A
Crh Plc stock logo
CRH
CRH
$37.45B1.99N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bovie Medical Co. stock logo
BVX
Bovie Medical
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Crh Plc stock logo
CRH
CRH
$3.73B$5.4020.6216.621.949.65%15.37%6.48%8/5/2026 (Estimated)

Latest CRH, BVX, and TSTL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2026Q1 2026
Crh Plc stock logo
CRH
CRH
-$0.2187-$0.20+$0.0187-$0.27$7.07 billion$7.37 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bovie Medical Co. stock logo
BVX
Bovie Medical
N/AN/AN/AN/AN/A
Crh Plc stock logo
CRH
CRH
$1.561.40%+10.50%28.89%N/A

Latest BVX, CRH, and TSTL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/30/2026
Crh Plc stock logo
CRH
CRH
quarterly$0.391.51%5/15/20265/15/20266/17/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bovie Medical Co. stock logo
BVX
Bovie Medical
N/AN/AN/A
Crh Plc stock logo
CRH
CRH
N/A
1.59
1.09

Institutional Ownership

CompanyInstitutional Ownership
Bovie Medical Co. stock logo
BVX
Bovie Medical
N/A
Crh Plc stock logo
CRH
CRH
62.50%

Insider Ownership

CompanyInsider Ownership
Bovie Medical Co. stock logo
BVX
Bovie Medical
N/A
Crh Plc stock logo
CRH
CRH
0.13%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bovie Medical Co. stock logo
BVX
Bovie Medical
N/A33.20 millionN/ANot Optionable
Crh Plc stock logo
CRH
CRH
83,032668.20 million667.33 millionOptionable

Recent News About These Companies

CRH plc (CRH) Arcosa, Inc., - M&A Call - Slideshow
CRH acquires Arcosa in $8.5 billion all-cash deal
CRH plc (CRH) M&A Call Transcript
Arcosa Stock Rises on $8.5 Billion Acquisition by CRH
Crh Plc $CRH Shares Purchased by Munro Partners

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bovie Medical stock logo

Bovie Medical NYSEAMERICAN:BVX

$6.48 +0.07 (+1.09%)
As of 12/31/2018

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

CRH stock logo

CRH NYSE:CRH

$111.33 +0.09 (+0.08%)
Closing price 06/22/2026 03:59 PM Eastern
Extended Trading
$110.71 -0.62 (-0.56%)
As of 08:38 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CRH plc, together with its subsidiaries, provides building materials solutions in Ireland and internationally. It operates through four segments: Americas Materials Solutions, Americas Building Solutions, Europe Materials Solutions, and Europe Building Solutions. The company provides solutions for the construction and maintenance of public infrastructure and commercial and residential buildings; and produces and sells aggregates, cement, readymixed concrete, and asphalt, as well as provides paving and construction services. It also manufactures, supplies, and delivers solutions for the built environment in communities across North America; and offers building and infrastructure solutions serving complex critical utility infrastructure, such as water, energy, transportation, and telecommunications projects, and outdoor living solutions for enhancing private and public spaces. In addition, the company combines materials, products, and services to produce a wide range of architectural and infrastructural solutions for use in the building and renovation of critical utility infrastructure, commercial and residential buildings, and outdoor living spaces for the built environment. Further, it produces and supplies precast and pre-stressed concrete products comprising floor and wall elements, beams, vaults, pipes, and manholes; granite, limestone, and sandstone; concrete and polymer-based products, such as underground vaults, drainage systems, utility enclosures, and modular precast structures; engineered steel, polymer-based anchoring, fixing, and connecting solutions; concrete masonry, hardscape and related products, including pavers, blocks and curbs, retaining walls, and slabs; and fencing and railing systems, composite decking, lawn and garden products, and packaged concrete mixes. The company was founded in 1936 and is headquartered in Dublin, Ireland.